Summary

Report Scope:

This report provides detailed information on the drug discovery technologies market. This report analyzes the market trends of drug discovery technologies with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024-2029), and regional markets of drug discovery technologies. This report highlights drug discovery technologies’ current and future market potential and gives a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints, and opportunities. This report also covers market projections for 2029 and the market share for key market players.

The market scope in this report is segmented into technologies and applications. Based on technologies, this report covers high-throughput screening (HTS), bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and others, such as combinatorial chemistry, metabolomics, nanotechnology, and system biology. These technologies are further classified into subcategories for this report. The market is segmented based on application to oncology, cardiovascular diseases, neurodegenerative diseases, immunological diseases, and others.

The market has been segmented into North America, Europe, Asia-Pacific, and other world regions. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for 2023, with forecasts for 2024 and projections for 2029.
The report’s goals include:
- Analyzing technologies and applications.
- Analyzing global market size and segmentation.
- Identifying market constraints and drivers.
- Providing detailed market forecasts through 2029.
- Assessing market shares, competitiveness, and industry structure.
- Identifying potential long-term impacts on the drug discovery technologies market.

Report Includes:

- 104 data tables and 34 additional tables
- An analysis of the current and future global markets for drug discovery technologies
- Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the global market for drug discovery technologies, with market share analysis by therapeutics, application, end user and region
- Discussion of bioinformatics as a platform for drug discovery
- A comparison between proteomics and genomics drug discovery technology
- Comparative assessment of pharmacokinetics and pharmacodynamics, and classification of the techniques used in drug discovery
- Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
- Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
- Competitive intelligence, including companies’ market shares, recent M&A activity and venture funding
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Agilent Technologies Inc., Illumina, and Charles River Laboratories.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Chapter 2 Market Overview
Overview
Porter’s Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
High-Content Screening (HCS) Techniques in Drug Discovery
Technological Advances
Demand for Personalized Medicine
Rising Prevalence of Chronic and Immunological Diseases
Growing Elderly Population
Availability of Research Funds
Market Restraints
Cost of the Drug Discovery Process and Instruments
Stringent Regulations
Better Understanding of Molecular Mechanisms
Market Opportunities
Potential for AI in Drug Discovery
Chapter 4 Emerging Technologies
Overview
AI
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Drug Discovery Technologies, by Technology
Global Market Forecast
High-Throughput Screening (HTS)
Bioanalytical Instruments
Genomics
Proteomics
Cell-Based Assays and Reagents
Bioinformatics
Other Technologies
Market for Drug Discovery Technologies, by Disease Application
Global Market Size and Forecast
Oncology
Cardiology
Neurodegenerative Diseases
Immunological Diseases
Other Diseases
Global Market for Drug Discovery Technologies, by End User
Global Market Size and Forecast
Biopharmaceutical Companies
Research and Academia
Contract Research Organizations (CROs)
Geographic Breakdown
Global Market for Drug Discovery Technologies, by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World
Chapter 6 Competitive Intelligence
Competitive Landscape
Analysis of Companies’ Market Shares
SWOT Analysis
Strengths
Challenges
Opportunities
Threats
Chapter 7 Sustainability in the Drug Delivery Technologies Market: An ESG Perspective
Introduction to ESG
Sustainability in the Drug Discovery Technologies Industry
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
BRUKER
CHARLES RIVER LABORATORIES
DANAHER CORP.
ILLUMINA INC.
PROMEGA CORP.
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.